News | July 07, 2022
Lonza to build large-scale fill & finish facility in Switzerland
The new facility will be delivered through an investment of approximately CHF 500 million and is expected to be completed in 2026
The new facility will be delivered through an investment of approximately CHF 500 million and is expected to be completed in 2026
Company is investing more than €100 million in the expansion of the Halle site
CEPI will provide seed funding of up to US$2.5 million to Codiak BioSciences.
The JV is funded by Boehringer Ingelheim as lead investor with 30 million EUR and by Evotec and bioMérieux with 5 million EUR each.
The investment will enable the company to provide customers with a complete and integrated end-to-end solution
The Government of Quebec, through its agent Investissement Quebec, is granting a loan of CAD 25 million
Condon joins DTx Pharma with more than 20 years of experience in business development, commercial planning, and operations.
States were also strongly advised to strictly monitor epidemiological profile of admitted COVID patients
The research here will mainly concentrate on the manufacturing process of biopharmaceuticals, especially in the area of advanced medicines, as well as the fermentation-based manufacture of ingredients for foods and food supplements
Dr. Rizo brings extensive industry leadership experience to Vividion, having held multiple senior executive roles during her career at both biotechnology and large pharmaceutical companies.
Subscribe To Our Newsletter & Stay Updated
